Do you know which symptoms might warrant consideration of the acute retroviral syndrome?
This AIDS specialist predicts that the era of 2-drug regimens will be upon us. He explains why here and writes, "remember: you read about it first here."
How far are we from achieving the goal of diagnosing and treating 90% of HIV-infected people to an undetectable HIV RNA level by 2020?
A new era of antiretroviral therapy was previewed at IDWeek 2015 where results of trials of a "next gen" Truvada were unveiled.
One US location has a higher incidence of HIV than “any country in sub-Saharan Africa.” What does this tell us about the inadequacies in our HIV prevention efforts?
Here's a summary of key recommendations for the primary care practitioner for the care of men who have sex with men from a recent article in The New England Journal of Medicine.
The newly published START trial conclusively demonstrates advantages of initiating antiretroviral therapy as soon as an HIV-infected person enters care.
CROI offers more than 1100 high-quality presentations and myriad poster sessions. You have so little time. Our CROI blogger offers 6 different ways to maximize learning at any jam-packed meeting, depending on your personal style.
The antiviral future holds great promise for people living with HIV: better-tolerated, less toxic, drugs are about to come to market, and we are about to see the introduction of drugs from 1 or 2 new classes.
Here is compelling reason why every MD needs to test his or her patients for HCV, and get them into therapy as soon as possible.